Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service

Diabet Med. 2022 May;39(5):e14816. doi: 10.1111/dme.14816. Epub 2022 Feb 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • Diabetes Mellitus* / therapy
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Insulin Infusion Systems
  • Secondary Care
  • United Kingdom

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin